NightHawk Biosciences Provides Q3 2023 Business Update
DURHAM, N.C., Nov. 20, 2023 (GLOBE NEWSWIRE) — NightHawk Biosciences (NYSE American: NHWK), a fully integrated biopharmaceutical company specializing in…
Pharmaceuticals, Biotechnology and Life Sciences
DURHAM, N.C., Nov. 20, 2023 (GLOBE NEWSWIRE) — NightHawk Biosciences (NYSE American: NHWK), a fully integrated biopharmaceutical company specializing in…
SOUTH SAN FRANCISCO, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical…
U.S. Department of Justice Declines ProsecutionCHASKA, Minn., Nov. 20, 2023 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”)…
AUSTIN, Texas, Nov. 20, 2023 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for…
CAMBRIDGE, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) — Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pioneering the…
STOCKHOLM, Sweden, Nov. 20, 2023 (GLOBE NEWSWIRE) — Vironova BioAnalytics, a leading provider of transmission electron microscopy (TEM) services, is…
TORONTO, Nov. 20, 2023 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE:PSYG) (“Psyence” or the “Company”), a clinical-stage life science biotechnology…
LA JOLLA, Calif., Nov. 19, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
TAIPEI, Taiwan and SAN DIGEO, Nov. 16, 2023 (GLOBE NEWSWIRE) — Polaris Group (The Company, TWSE:6550), today announced that the…
GENFIT highlighted new focus and development strategy in Acute On-Chronic Liver Failure (ACLF)ACLF is a very serious condition affecting ~294,0001…